Development of colitis in signal transducers and activators of transcription 6-deficient T-cell receptor α-deficient mice: A potential role of signal transducers and activators of transcription 6-independent interleukin-4 signaling for the generation of Th2-biased pathological CD4+ ββT cells

American Journal of Pathology

Volumn 162, Issue 1, 2003, Pages 263-271

  Okuda, Yoshiko ^a,b   Takahashi, Ichiro ^a,d   Kim, Jin Kyung ^a   Ohta, Noriyuki ^a   Iwatani, Kouichi ^a   Iijima, Hideki ^a,b   Kai, Yasuyuki ^a   Tamagawa, Hiroshi ^a   Hiroi, Takachika ^a   Kweon, Mi Na ^a   Kawano, Sunao ^b   Takeda, Kiyoshi ^a   Akira, Sizuo ^a   Sasaki, Yutaka ^b   Hori, Masatsugu ^b   Kiyono, Hiroshi ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE ANTIBODY; INTERLEUKIN 4; MONOCLONAL ANTIBODY; STAT6 PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; GENE DELETION; INTESTINE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH2 CELL;

EID: 0037222318     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63817-5     Document Type: Article

References (68)

1. Powrie F: T cells in inflammatory bowel disease: Protective and pathogenic roles. Immunity 1995, 3:171-174
2. Blumberg RS, Saubermann L, Strober W: Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999, 11:648-656
3. Strober W, Ehrhardt RO: Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice. Cell 1993, 75:203-205
4. Sartor RB: Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994, 106:533-539
5. Podolsky DK: Inflammatory bowel disease (1). N Engl J Med 1991, 325:928-937
6. Niessner M, Volk BA: Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995, 101:428-435
7. West GA, Matsuura T, Levine AD, Klein JS, Fiocchi C: Interleukine 4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology 1996, 110:1683-1695
8. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996, 157:1261-1270
9. Parroncai P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S: Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997, 150:823-832
10. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S: Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993, 75:274-282
11. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulceralive colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261
12. Watanabe M, Ueno Y, Yajima T, Okamoto S, Hayashi T, Yamazaki M, Iwao Y, Ishii H, Habu S, Uehira M, Nishimoto H, Ishikawa H, Hata J, Hibi T: Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med 1998, 187:389-402
13. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274
14. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S: Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49
15. i2-deficient mice. Nat Genet 1995, 10:143-150
16. + T cells. J Exp Med 1993, 178:237-244
17. Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Nagler-Anderson C, Bhan AK: Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996, 183:847-856
18. + T-cell population mediates development of inflammatory bowel disease in T-cell receptor α chain-deficient mice. Gastroenterology 1997, 112:1876-1886
19. Iijima H, Takahashi I, Kishi D, Kim JK, Kawano S, Hori M, Kiyono H: Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor α chain-deficient mice. J Exp Med 1999, 190:607-615
20. Mizoguchi A, Mizoguchi E, Bhan AK: The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor α mutant mice. Gastroenterology 1999, 116:320-326
21. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR: Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999, 189:1169-1180
22. Boirivant M, Fuss IJ, Chu A, Strober W: Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998, 188:1929-1939
23. + T cells in TCR α-chain-deficient mice by gut-derived antigens. J Immunol 1999, 162:1843-1850
24. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of Stat6 in IL-4 signalling. Nature 1996, 380:627-630
25. Takeda K, Kishimoto T, Akira S: STAT6: Its role in interleukin 4-mediated biological functions J Mol Med 1997, 75:317-326
26. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE: The IL-4 receptor: Signaling mechanisms and biologic functions. Annu Rev Immunol 1999, 17:701-738
27. Hughes DP, Hayday A, Craft JE, Owen MJ, Crispe IN: T cells with γ/δT cell receptors (TCR) of intestinal type are preferentially expanded in TCRα-deficient Ipr mice. J Exp Med 1995, 182:233-241
28. hi T cells. J Exp Med 1999, 190:1479-1492
29. + T cells provide B cell help. J Exp Med 1992, 175:695-707
30. Takahashi I, Kiyono H, Jackson RJ, Fujihashi K, Staats HF, Hamada S, Clements JD, Bost KL, McGhee JR: Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine. Infect Immun 1996, 64:1290-1298
31. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ: The LightCycler: A microvolume multisample fluorimeter with rapid temperature control. BioTechniques 1997, 22:176-181
32. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP: Continuous fluorescence monitoring of rapid cycle DNA amplification. BioTechniques 1997; 22:130-148
33. Hiroi T, Yanagita M, Ohta N, Sakaue G, Kiyono H: IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses. J Immunol 2000, 165:4329-4337
34. Yanagita M, Hiroi T, Kitagaki N, Hamada S, Ito H, Shimauchi H, Murakami S, Okada H, Kiyono H: Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: Fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J Immunol 1999, 162:3559-3565
35. Hiroi T, Fujihashi K, McGhee JR, Kiyono H: Polarized Th2 cytokine expression by both mucosal γδ and αβ T cells. Eur J Immunol 1995, 25:2743-2751
36. Overbergh L, Valckx D, Waer M, Mathieu C: Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 1999, 11:305-312
37. Yoneyama H, Harada A, Imai T, Baba M, Yoshie O, Zhang Y, Higashi H, Murai M, Asakura H, Matsushima K: Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest 1998, 102:1933-1941
38. + TCR ββ homodimer T cells by elimination of Bacteroides vulgatus prevents colitis in TCR α-chain-deficient mice. J Immunol 2000, 165:5891-5899
39. Takahashi I, Iijima H, Kishi D, Kiyono H: Oligoclonal Th2-biased ββ T cells induce murine inflammatory bowel disease. Immunol Res 1999, 20:237-242
40. Kaplan MH, Schindler U, Smiley ST, Grusby MJ: STAT6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996, 4:313-319
41. Kaplan MH, Wurster AL, Smiley ST, Grusby MJ: Stat6-dependent and -independent pathways for IL-4 production. J Immunol 1999, 163: 6536-6540
42. Zhu J, Guo L, Watson CJ, Hu-Li J, Paul WE: Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol 2001, 166:7276-7281
43. Tomkinson A, Kanehiro A, Rabinovitch N, Joetham A, Cieslewicz G, Gelfand EW: The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am J Respir Crit Care Med 1999, 160:1283-1291
44. + T cells. Clin Exp Allergy 1999, 29:114-123
45. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL: Signaling and transcription in T helper development. Annu Rev Immunol 2000, 18:451-494
46. Ouyang W, Lohning M, Gao Z, Assenmacher M, Ranganath S, Radbruch A, Murphy KM: Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 2000, 12:27-37
47. Farrar JD, Ouyang W, Lohning M, Assenmacher M, Radbruch A, Kanagawa O, Murphy KM: An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3. J Exp Med 2001, 193:643-649
48. Zheng W, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596
49. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM: Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998, 9:745-755
50. Ferber IA, Lee HJ, Zonin F, Heath V, Mui A, Arai N, O'Garra A: GATA-3 significantly downregulates IFN-γ production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin Immunol 1999, 91:134-144
51. Bird JJ, Brown DR, Mullen AC, Moskowitz NH, Mahowald MA, Sider JR, Gajewski TF, Wang CR, Reiner SL: Helper T cell differentiation is controlled by the cell cycle Immunity 1998, 9:229-237
52. Agarwal S, Rao A: Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 1998, 9:765-775
53. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers Jr MGJ, Glasheen E, Lane WS, Pierce JH, White MF: Role of IRS-2 in insulin and cytokine signaling. Nature 1995, 377:173-177
54. Wery S, Letourneur M, Bertoglio J, Pierre J: Interleukin-4 induces activation of mitogen-activated protein kinase and phosphorylation of shc in human keratinocytes. J Biol Chem 1996, 271:8529-8532
55. Nelms K, Snow AL, Hu-Li J, Paul WE: FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity 1998, 9:13-24
56. Zhang DH, Yang L, Ray A: Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J Immunol 1998, 161: 3817-3821
57. Ho IC, Hodge MR, Rooney JW, Glimcher LH: The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996, 85:973-983
58. + T helper 2 (Th2) cells but not in Th1 cells. Mol Cell Biol 1997, 17:1522-1534
59. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM: Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997, 276:589-592
60. Hartatik T, Okada S, Okabe S, Arima M, Hatano M, Tokuhisa T: Binding of BAZF and Bc16 to STAT6-binding DNA sequences. Biochem Biophys Res Commun 2001, 284:26-32
61. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R: The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997, 16:161-170
62. Dent AL, Hu-Li J, Paul WE, Staudt LM: T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc Natl Acad Sci USA 1998, 95:13823-13828
63. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS: A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 1998, 161:1501-1509
64. Pearce EJ, Cheever A, Leonard S, Covalesky M, Fernandez-Botran R, Kohler G, Kopf M: Schistosoma mansoni in IL-4-deficient mice. Int Immunol 1996, 8:435-444
65. Brewer JM, Conacher M, Satoskar A, Bluethmann H, Alexander J: In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. Eur J Immunol 1996, 26:2062-2066
66. + T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci USA 1997, 94:10838-10843
67. Kaplan MH, Whitfield JR, Boros DL, Grusby MJ: Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol 1998, 160:1850-1856
68. + lymphocytes with a Th2 cytokine profile. J Immunol 2000, 164:3047-3055